AI assistant
ULTRALIFE CORP — Director's Dealing 2021
Aug 12, 2021
34105_dirs_2021-08-12_aaf9567d-6e54-40bb-a283-534acb67c27a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ULTRALIFE CORP (ULBI)
CIK: 0000875657
Period of Report: 2021-08-10
Reporting Person: POPIELEC MICHAEL D (Director, Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock; $.10 par value | M | 12709 | $3.7103 | Acquired | 309926 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Stock Options | $3.7103 | M | 40000 | Disposed | 2022-03-03 | Common Stock (40000) | Direct |
Footnotes
F1: (1) Represents shares of common stock acquired by the Reporting Person upon exercise of options for 40,000 shares of common stock of the Company, net of 27,291 shares of common stock retained by the Company at a price determined pursuant to the terms of the Company's 2014 Long Term Incentive Plan in payment of the exercise price for the options and the Reporting Person's individual tax withholdings.
F2: (2) Represents exercise of options for 40,000 shares of common stock of the Company otherwise expiring on 3/3/2022.